Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $284,571 - $392,581
-3,299 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $66,412 - $83,776
663 Added 25.15%
3,299 $368,000
Q2 2021

Aug 11, 2021

BUY
$86.05 - $119.72 $226,827 - $315,581
2,636 New
2,636 $299,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.